Rosé J - Search Results

1

Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation.

Babé LM, Rosé J, Craik CS. Babé LM, et al. Among authors: rose j. Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10069-73. doi: 10.1073/pnas.92.22.10069. Proc Natl Acad Sci U S A. 1995. PMID: 7479728 Free PMC article.

2

Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity.

Rosé JR, Babé LM, Craik CS. Rosé JR, et al. J Virol. 1995 May;69(5):2751-8. doi: 10.1128/JVI.69.5.2751-2758.1995. J Virol. 1995. PMID: 7535864 Free PMC article.

3

Structure-assisted design of nonpeptide human immunodeficiency virus-1 protease inhibitors.

Rosé JR, Craik CS. Rosé JR, et al. Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 2):S176-82. doi: 10.1164/ajrccm/150.6_Pt_2.S176. Am J Respir Crit Care Med. 1994. PMID: 7952656 Review.

4

In vitro characterization of nonpeptide irreversible inhibitors of HIV proteases.

Salto R, Babé LM, Li J, Rosé JR, Yu Z, Burlingame A, De Voss JJ, Sui Z, Ortiz de Montellano P, Craik CS. Salto R, et al. Among authors: rose jr. J Biol Chem. 1994 Apr 8;269(14):10691-8. J Biol Chem. 1994. PMID: 8144659 Free article.

5

Engineering catalytically defective forms of HIV protease to modulate its activity.

Craik CS, Babé LM, Dauber D, McPhee F, Rosé J, Unal A. Craik CS, et al. Among authors: rose j. Adv Exp Med Biol. 1998;436:31-9. doi: 10.1007/978-1-4615-5373-1_4. Adv Exp Med Biol. 1998. PMID: 9561196 Review. No abstract available.

6

Structure of the protease from simian immunodeficiency virus: complex with an irreversible nonpeptide inhibitor.

Rose RB, Rosé JR, Salto R, Craik CS, Stroud RM. Rose RB, et al. Among authors: rose jr. Biochemistry. 1993 Nov 23;32(46):12498-507. doi: 10.1021/bi00097a030. Biochemistry. 1993. PMID: 8241141

7

Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions.

Rosé JR, Salto R, Craik CS. Rosé JR, et al. J Biol Chem. 1993 Jun 5;268(16):11939-45. J Biol Chem. 1993. PMID: 8505318 Free article.

8

Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines.

Junker U, Escaich S, Plavec I, Baker J, McPhee F, Rose JR, Craik CS, Böhnlein E. Junker U, et al. Among authors: rose jr. J Virol. 1996 Nov;70(11):7765-72. doi: 10.1128/JVI.70.11.7765-7772.1996. J Virol. 1996. PMID: 8892897 Free PMC article.

9

Synthetic "interface" peptides alter dimeric assembly of the HIV 1 and 2 proteases.

Babé LM, Rosé J, Craik CS. Babé LM, et al. Among authors: rose j. Protein Sci. 1992 Oct;1(10):1244-53. doi: 10.1002/pro.5560011003. Protein Sci. 1992. PMID: 1338945 Free PMC article.

10

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.

Richman D, Shih CK, Lowy I, Rose J, Prodanovich P, Goff S, Griffin J. Richman D, et al. Among authors: rose j. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11241-5. doi: 10.1073/pnas.88.24.11241. Proc Natl Acad Sci U S A. 1991. PMID: 1722324 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,201 results

Search Page

Filters